S-1: Natures Miracle Holding Inc. Files for Potential $20 Million Equity Line of Credit

Natures Miracle Holding Inc. is seeking to raise up to $20 million through an equity line of credit and resale of existing shares, according to an S-1 filing.

Summary

• Natures Miracle Holding Inc. filed a Form S-1 registration statement with the SEC on May 6, 2025.
• The filing covers the potential offer and sale of up to 55,817,669 shares of Common Stock to GHS Investments, LLC through an equity line of credit (ELOC) for up to $20,000,000.
• It also includes the offer and sale of 1,503,759 shares of Common Stock issued to the Investor as an equity incentive and 2,678,571 shares of Common Stock that may be issued upon conversion of Series A Preferred Stock.
• The company may receive up to $20,000,000 over the next 24 months upon the issuance of shares of Common Stock under the EPFA.
• The Investor will be obligated to buy registered Common Stock from time to time, when directed by the Company through a Purchase Notice.
• The maximum dollar amount of each Purchase shall equal 200% the average of the daily trading dollar volume for the Company's Common Stock during the ten trading days preceding the Purchase Notice Date.
• No Purchase will be made in an amount less than $10,000 or greater than $500,000.
• The Investor may not be issued shares resulting in it owning more than 4.99% of the total outstanding Common Stock at any given time.
• The purchase price for each Purchase shall equal 80% of the lowest traded price for the Company's Common Stock during the ten consecutive trading days immediately preceding the relevant Purchase Notice Date, subject to a floor price of $0.05 per share.
• The company intends to use the proceeds from this offering for general corporate purposes, including working capital and investments.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While it outlines a potential funding opportunity, it also acknowledges significant risks, operating losses, and potential dilution for existing shareholders. The 'worse' expected alert further contributes to a negative outlook.

Positives

• The equity line of credit provides a potential source of funding for general corporate purposes.
• The company retains control over the timing and amount of shares sold under the EPFA.
• The Investor is obligated to buy registered Common Stock from time to time, when directed by the Company through a Purchase Notice.

Negatives

• The sale of a substantial number of shares of Common Stock by the Selling Stockholders could cause the price of our Common Stock to decline.
• Future resales and/or issuances of shares of Common Stock, including pursuant to this prospectus, or the perception that such sales may occur, may cause the market price of our shares to drop significantly.
• It is not possible to predict the actual number of shares of our Common Stock, if any, we will sell under the EPFA, or the actual gross proceeds resulting from those sales or the dilution to you from those sales. Further, we may not have access to the full amount available under the EPFA.
• Investors who buy shares of Common Stock from the Selling Stockholders or the Investor at different times will likely pay different prices.

Risks

• The market price of the company's Common Stock could decline due to sales by Selling Stockholders.
• Future equity offerings may dilute existing stockholders' ownership.
• The company's limited operating history in the CEA industry makes it difficult to accurately forecast future operating results.
• The company has incurred substantial operating losses since 2022 and there is substantial doubt about our ability to continue as a going concern.
• The Investor will pay less than the then-prevailing market price for our Common Stock, which could cause the price of our Common Stock to decline.

Future Outlook

The company intends to use the proceeds from this offering for general corporate purposes, including working capital and investments.

Industry Context

The document highlights the company's position in the agriculture technology sector, specifically Controlled Environment Agriculture (CEA), which is experiencing growth due to factors like increased demand for food security and sustainable practices. The company's expansion into electric vehicle (EV) distribution and data centers reflects a diversification strategy.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or competitors.
• It mentions the benefits of CEA indoor farming compared to traditional agriculture, such as greater product safety, climate-agnostic crop supply, and lower water and pesticide use.
• However, it lacks detailed benchmarking against specific companies or projects.

Legal Proceedings

• The document mentions ongoing litigation, including a lawsuit by Megaphoton and a complaint by Beverly Hills View, Inc.

Related Party Transactions

• The document mentions a convertible promissory note with Big Lake Capital, LLC, controlled by Tie (James) Li, the company's Chairman and CEO.

Stakeholder Impact

• Existing shareholders may experience dilution due to the issuance of new shares.
• The company's ability to fund operations and growth may be affected by the success of the equity line of credit.
• The market price of the company's Common Stock could be influenced by sales by Selling Stockholders.

Next Steps

• The company will seek to have the Registration Statement declared effective by the SEC.
• The company may issue Purchase Notices to the Investor to draw down on the equity line of credit.
• The company intends to use the net proceeds for working capital and general corporate purposes.

Key Dates

Keywords

equity line of credit, common stock, registration statement, ELOC, GHS Investments, Natures Miracle, financing, shares, investor, EPFA